Abstract
Objectives
To investigate the effect of bifocal wearing in the amblyopic eye when atropine is used in the sound eye for the treatment of hyperopic anisometropic amblyopia.
Methods
Children 4–8 years old were randomly assigned to bifocal + atropine (n = 16) or only atropine (control, n = 19) groups of treatment in a proof-of-concept study. Measurements included visual acuity (logMAR), prism and cover test, stereoacuity (Randot preschool or Randot circles), contrast sensitivity (MARS test), accommodation (Grand Seiko WAM5500 and dynamic retinoscopy), retinoscopic and subjective refraction, before starting treatment and at 6 months, except accommodation, which was remeasured at 9–11 months. Main outcome measure was change in logMAR lines of visual acuity, and secondary outcome measures were change in stereoacuity and contrast sensitivity in the amblyopic eye, at 6 months.
Results
Improvement in visual acuity of the amblyopic eye was significantly better (p = 0.04) in the atropine plus bifocal (3.3 ± 0.9 logMAR lines) than in the atropine only group (2.6 ± 0.8 logMAR lines), whereas change in stereoacuity and contrast sensitivity was not significantly different between the two groups. Differences in accommodative gain, which was impaired in the amblyopic compared to the sound eye, before treatment, decreased after treatment, in the atropine group (0.62 ± 0.16 vs 0.79 ± 0.2, p = 0.3), and atropine + bifocal group (0.69 ± 0.15 vs 0.82 ± 0.2, p = 0.4).
Conclusions
Use of bifocal lens add in the amblyopic eye of children with hyperopic anisometropic amblyopia, treated by atropine penalization, is beneficial in the follow-up period of 6 months.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 18 print issues and online access
$259.00 per year
only $14.39 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
Data available from the corresponding author upon reasonable request.
References
Repka MX. Amblyopia outcomes through clinical trials and practice measurement: room for improvement: The LXXVII Edward Jackson Memorial Lecture. Am J Ophthalmol. 2020;219:A1–26.
Woodruff G, Hiscox F, Thompson JR, Smith LK. Factors affecting the outcome of children treated for amblyopia. Eye. 1994;8:627–31.
Stewart CE, Moseley MJ, Stephens DA, Fielder AR. Treatment dose-response in amblyopia therapy: the Monitored Occlusion Treatment of Amblyopia Study (MOTAS). Invest Ophthalmol Vis Sci. 2004;45:3048–54.
Repka MX, Wallace DK, Beck RW, Kraker RT, Birch EE, Cotter SA, et al. Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 2005;123:149–57.
Birch EE. Amblyopia and binocular vision. Prog Retin Eye Res. 2013;33:67–84.
Candy TR, Wang J, Ravikumar S. Retinal image quality and postnatal visual experience during infancy. Optom Vis Sci. 2009;86:E556–71.
Hokoda SC, Ciuffreda KJ. Measurement of accommodative amplitude in amblyopia. Ophthalmic Physiol Opt. 1982;2:205–12.
Ciuffreda KJ, Hokoda SC, Hung GK, Semmlow JL. Accommodative stimulus/response function in human amblyopia. Doc Ophthalmol. 1984;56:303–26.
Ciuffreda KJ, Rumpf D. Contrast and accommodation in amblyopia. Vis Res. 1985;25:1445–57.
Bradley A, Freeman RD. Contrast sensitivity in anisometropic amblyopia. Invest Ophthalmol Vis Sci. 1981;21:467–76.
Toor S, Horwood AM, Riddell P. Asymmetrical accommodation in hyperopic anisometropic amblyopia. Br J Ophthalmol. 2018;102:772–8.
Toor S, Horwood AM, Riddell P. The effect of asymmetrical accommodation on anisometropic amblyopia treatment outcomes. J AAPOS. 2019;23:203.e1–5.
Author information
Authors and Affiliations
Contributions
JT contributed to the conception and design of the study, data acquisition, statistical analysis, analysis and interpretation of results, and writing the draft and final version of the manuscript. FJGC contributed to the conception and design of the study, analysis and interpretation of results, writing the draft, revising it critically, and obtaining the final version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Tejedor, J., Gutiérrez-Carmona, F.J. Bifocal use in hyperopic anisometropic amblyopia treated with atropine: a proof-of-concept randomized trial. Eye 37, 1840–1843 (2023). https://doi.org/10.1038/s41433-022-02247-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41433-022-02247-4